S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
Log in

BIO-key International Stock Price, Forecast & Analysis (NASDAQ:BKYI)

$0.55
+0.04 (+7.84 %)
(As of 11/20/2019 04:00 PM ET)
Today's Range
$0.51
Now: $0.55
$0.56
50-Day Range
$0.51
MA: $0.59
$0.70
52-Week Range
$0.50
Now: $0.55
$1.62
Volume4,900 shs
Average Volume20,588 shs
Market Capitalization$7.92 million
P/E RatioN/A
Dividend YieldN/A
Beta2.27
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. The company's products include Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. Its products also comprise ID Director, a solution for single sign on integration with CA Technologies SiteMinder, Oracle's Fusion Middleware SSO, IBM Tivoli Access Manager, and other solutions; and WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in insecure environments, such as the world wide Web or off-site cloud environments. The company also sells third-party hardware components. BIO-key International, Inc. markets its products through its direct sales force, as well as through distributors, resellers, integrators, and partner networks to government and corporate customers primarily in North America. It has strategic partnership with Quantum Business Advisory to bring its software and hardware solutions to enterprises in India. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Industry, Sector and Symbol

Industry Computer & office equipment
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:BKYI
CUSIPN/A
Phone732-359-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.05 million
Book Value$0.75 per share

Profitability

Net Income$-6,870,000.00
Net Margins-186.77%

Miscellaneous

Employees18
Market Cap$7.92 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive BKYI News and Ratings via Email

Sign-up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.


BIO-key International (NASDAQ:BKYI) Frequently Asked Questions

What is BIO-key International's stock symbol?

BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) released its earnings results on Friday, November, 15th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.08. The technology company had revenue of $0.45 million for the quarter. BIO-key International had a negative net margin of 186.77% and a negative return on equity of 73.92%. View BIO-key International's Earnings History.

When is BIO-key International's next earnings date?

BIO-key International is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for BIO-key International.

What price target have analysts set for BKYI?

1 brokerages have issued twelve-month target prices for BIO-key International's stock. Their forecasts range from $2.00 to $2.00. On average, they expect BIO-key International's stock price to reach $2.00 in the next year. This suggests a possible upside of 263.6% from the stock's current price. View Analyst Price Targets for BIO-key International.

What is the consensus analysts' recommendation for BIO-key International?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIO-key International in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for BIO-key International.

Has BIO-key International been receiving favorable news coverage?

News coverage about BKYI stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. BIO-key International earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for BIO-key International.

Are investors shorting BIO-key International?

BIO-key International saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,000 shares, an increase of 25.0% from the September 30th total of 800 shares. Based on an average daily trading volume, of 24,400 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company's shares are short sold. View BIO-key International's Current Options Chain.

Who are some of BIO-key International's key competitors?

What other stocks do shareholders of BIO-key International own?

Who are BIO-key International's key executives?

BIO-key International's management team includes the folowing people:
  • Mr. Michael W. DePasquale, Chairman & CEO (Age 64)
  • Ms. Cecilia C. Welch, Chief Financial Officer (Age 59)
  • Ms. Mira K. LaCous, Chief Technology Officer (Age 57)
  • Mr. Scott Mahnken, VP of Marketing (Age 59)
  • Mr. James Sullivan, Sr. VP of Strategy & Bus. Devel. (Age 52)

How do I buy shares of BIO-key International?

Shares of BKYI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BIO-key International's stock price today?

One share of BKYI stock can currently be purchased for approximately $0.55.

How big of a company is BIO-key International?

BIO-key International has a market capitalization of $7.92 million and generates $4.05 million in revenue each year. BIO-key International employs 18 workers across the globe.View Additional Information About BIO-key International.

What is BIO-key International's official website?

The official website for BIO-key International is http://www.bio-key.com/.

How can I contact BIO-key International?

BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company can be reached via phone at 732-359-1100 or via email at [email protected]


MarketBeat Community Rating for BIO-key International (NASDAQ BKYI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  269
MarketBeat's community ratings are surveys of what our community members think about BIO-key International and other stocks. Vote "Outperform" if you believe BKYI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BKYI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: What is the Quick Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel